Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 1, 2020
Clear
SKU: GMS-1210 Category:

The global market for hepatitis test solution/diagnosis is expected to reach USD 3.55 billion by 2024, growing over the forecast period at a CAGR of 4.52%. This market is driven by factors such as the high burden of hepatitis worldwide, growing blood transfusions and donations, PoC instruments & kits benefits, and awareness campaigns.

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 1

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 2

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 3

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 4

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 5

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 6

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 7

Hepatitis Test Solution/Diagnosis Market by Disease Type (HCV, HAV, HDV, Hepatitis B), End User (Blood Banks, Nursing Homes, Diagnostic Laboratories, Hospitals), Technology (Transcription Mediated Amplification, PCR, ELISA, RDT) - 2019 to 2024 8

1 Global Hepatitis Test Solution/Diagnosis Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Hepatitis Test Solution/Diagnosis Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Hepatitis Test Solution/Diagnosis Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Hepatitis Test Solution/Diagnosis Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Hepatitis Test Solution/Diagnosis Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Hepatitis Test Solution/Diagnosis Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Hepatitis Test Solution/Diagnosis Market – By Disease Type (Market Size – &
million/billion)
8.1 Hepatitis B
8.2 Hepatitis C
8.3 Other

9 Global Hepatitis Test Solution/Diagnosis Market – By Technology
9.1 ELISA
9.2 Rapid Diagnostics test
9.3 PCR
9.4 INAAT
9.5 Other

10 Global Hepatitis Test Solution/Diagnosis Market – By End-User
10.1 Hospitals & Diagnostics Labs
10.2 Blood Banks
10.3 Other

11 Global Hepatitis Test Solution/Diagnosis Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Hepatitis Test Solution/Diagnosis Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Hepatitis Test Solution/Diagnosis Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Abbott Laboratories, Inc.
13.3 Roche Diagnostics
13.4 Bio-Rad Laboratories
13.5 Siemens Healthineers
13.6 Biomérieux Sa
13.7 Ortho Clinical Diagnostic
13.8 Diasorin
13.9 Qiagen
13.10 Danaher Corporation
13.11 Grifols
13.12 Company 11 & more

14 Global Hepatitis Test Solution/Diagnosis Market – Appendix
14.1 Sources
14.2 Abbreviations